Kobayashi Pharmaceutical Co., Ltd. provided earnings guidance for the full year of 2022. The company expected to achieve sales target with a little margin, but on the profit side, the company have not achieved cost reduction plan, raw material prices continue to rise, and fixed and distribution costs are increasing. In response, will work to achieve projected operating income while curbing advertising expenses and reducing other costs.